Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size was estimated at USD 3623.58 million in 2023 and is projected to reach USD 7544.11 million by 2029, exhibiting a CAGR of 13.00% during the forecast period.
This report provides a deep insight into the global Paroxysmal Nocturnal Hemoglobinuria Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Paroxysmal Nocturnal Hemoglobinuria Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Paroxysmal Nocturnal Hemoglobinuria Drug market in any manner.
Global Paroxysmal Nocturnal Hemoglobinuria Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Apellis Pharmaceuticals
Alexion Pharmaceuticals Inc
Akari Therapeutics Plc
CinnaGen Co
Ra Pharmaceuticals Inc
Amgen Inc
Achillion Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
F. Hoffmann-La Roche Ltd
Novartis AG
Regeneron Pharmaceuticals Inc
BIOCAD
Samsung Bioepis
Amyndas Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
LGM Pharma.
Lannett
NorthStar Rx LLC
Abbott
Par Pharmaceutical
Market Segmentation (by Type)
Eculizumab
Ravulizumab
Others
Market Segmentation (by Application)
Clinic
Hospital
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Paroxysmal Nocturnal Hemoglobinuria Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size was estimated at USD 3623.58 million in 2023 and is projected to reach USD 7544.11 million by 2029, exhibiting a CAGR of 13.00% during the forecast period.
This report provides a deep insight into the global Paroxysmal Nocturnal Hemoglobinuria Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Paroxysmal Nocturnal Hemoglobinuria Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Paroxysmal Nocturnal Hemoglobinuria Drug market in any manner.
Global Paroxysmal Nocturnal Hemoglobinuria Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Apellis Pharmaceuticals
Alexion Pharmaceuticals Inc
Akari Therapeutics Plc
CinnaGen Co
Ra Pharmaceuticals Inc
Amgen Inc
Achillion Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
F. Hoffmann-La Roche Ltd
Novartis AG
Regeneron Pharmaceuticals Inc
BIOCAD
Samsung Bioepis
Amyndas Pharmaceuticals
Teva Pharmaceutical Industries Ltd.
LGM Pharma.
Lannett
NorthStar Rx LLC
Abbott
Par Pharmaceutical
Market Segmentation (by Type)
Eculizumab
Ravulizumab
Others
Market Segmentation (by Application)
Clinic
Hospital
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Paroxysmal Nocturnal Hemoglobinuria Drug Market
- Overview of the regional outlook of the Paroxysmal Nocturnal Hemoglobinuria Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Paroxysmal Nocturnal Hemoglobinuria Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Paroxysmal Nocturnal Hemoglobinuria Drug
1.2 Key Market Segments
1.2.1 Paroxysmal Nocturnal Hemoglobinuria Drug Segment by Type
1.2.2 Paroxysmal Nocturnal Hemoglobinuria Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Manufacturers (2019-2024)
3.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Sales Sites, Area Served, Product Type
3.6 Paroxysmal Nocturnal Hemoglobinuria Drug Market Competitive Situation and Trends
3.6.1 Paroxysmal Nocturnal Hemoglobinuria Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Paroxysmal Nocturnal Hemoglobinuria Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG INDUSTRY CHAIN ANALYSIS
4.1 Paroxysmal Nocturnal Hemoglobinuria Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2019-2024)
6.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Market Share by Type (2019-2024)
6.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Type (2019-2024)
7 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Sales by Application (2019-2024)
7.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Growth Rate by Application (2019-2024)
8 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET SEGMENTATION BY REGION
8.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
8.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
8.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Apellis Pharmaceuticals
9.1.1 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.1.2 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.1.3 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.1.4 Apellis Pharmaceuticals Business Overview
9.1.5 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
9.1.6 Apellis Pharmaceuticals Recent Developments
9.2 Alexion Pharmaceuticals Inc
9.2.1 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.2.2 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.2.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.2.4 Alexion Pharmaceuticals Inc Business Overview
9.2.5 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
9.2.6 Alexion Pharmaceuticals Inc Recent Developments
9.3 Akari Therapeutics Plc
9.3.1 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.3.2 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.3.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.3.4 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
9.3.5 Akari Therapeutics Plc Business Overview
9.3.6 Akari Therapeutics Plc Recent Developments
9.4 CinnaGen Co
9.4.1 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.4.2 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.4.3 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.4.4 CinnaGen Co Business Overview
9.4.5 CinnaGen Co Recent Developments
9.5 Ra Pharmaceuticals Inc
9.5.1 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.5.2 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.5.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.5.4 Ra Pharmaceuticals Inc Business Overview
9.5.5 Ra Pharmaceuticals Inc Recent Developments
9.6 Amgen Inc
9.6.1 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.6.2 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.6.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.6.4 Amgen Inc Business Overview
9.6.5 Amgen Inc Recent Developments
9.7 Achillion Pharmaceuticals Inc
9.7.1 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.7.2 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.7.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.7.4 Achillion Pharmaceuticals Inc Business Overview
9.7.5 Achillion Pharmaceuticals Inc Recent Developments
9.8 Alnylam Pharmaceuticals Inc
9.8.1 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.8.2 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.8.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.8.4 Alnylam Pharmaceuticals Inc Business Overview
9.8.5 Alnylam Pharmaceuticals Inc Recent Developments
9.9 F. Hoffmann-La Roche Ltd
9.9.1 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.9.2 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.9.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.9.4 F. Hoffmann-La Roche Ltd Business Overview
9.9.5 F. Hoffmann-La Roche Ltd Recent Developments
9.10 Novartis AG
9.10.1 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.10.2 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.10.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.10.4 Novartis AG Business Overview
9.10.5 Novartis AG Recent Developments
9.11 Regeneron Pharmaceuticals Inc
9.11.1 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.11.2 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.11.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.11.4 Regeneron Pharmaceuticals Inc Business Overview
9.11.5 Regeneron Pharmaceuticals Inc Recent Developments
9.12 BIOCAD
9.12.1 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.12.2 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.12.3 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.12.4 BIOCAD Business Overview
9.12.5 BIOCAD Recent Developments
9.13 Samsung Bioepis
9.13.1 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.13.2 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.13.3 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.13.4 Samsung Bioepis Business Overview
9.13.5 Samsung Bioepis Recent Developments
9.14 Amyndas Pharmaceuticals
9.14.1 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.14.2 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.14.3 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.14.4 Amyndas Pharmaceuticals Business Overview
9.14.5 Amyndas Pharmaceuticals Recent Developments
9.15 Teva Pharmaceutical Industries Ltd.
9.15.1 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.15.2 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.15.3 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.15.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9.16 LGM Pharma.
9.16.1 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.16.2 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.16.3 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.16.4 LGM Pharma. Business Overview
9.16.5 LGM Pharma. Recent Developments
9.17 Lannett
9.17.1 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.17.2 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.17.3 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.17.4 Lannett Business Overview
9.17.5 Lannett Recent Developments
9.18 NorthStar Rx LLC
9.18.1 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.18.2 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.18.3 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.18.4 NorthStar Rx LLC Business Overview
9.18.5 NorthStar Rx LLC Recent Developments
9.19 Abbott
9.19.1 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.19.2 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.19.3 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.19.4 Abbott Business Overview
9.19.5 Abbott Recent Developments
9.20 Par Pharmaceutical
9.20.1 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.20.2 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.20.3 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.20.4 Par Pharmaceutical Business Overview
9.20.5 Par Pharmaceutical Recent Developments
10 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET FORECAST BY REGION
10.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast
10.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country
10.2.3 Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Region
10.2.4 South America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Paroxysmal Nocturnal Hemoglobinuria Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Paroxysmal Nocturnal Hemoglobinuria Drug by Type (2025-2030)
11.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Paroxysmal Nocturnal Hemoglobinuria Drug by Type (2025-2030)
11.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Forecast by Application (2025-2030)
11.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Paroxysmal Nocturnal Hemoglobinuria Drug
1.2 Key Market Segments
1.2.1 Paroxysmal Nocturnal Hemoglobinuria Drug Segment by Type
1.2.2 Paroxysmal Nocturnal Hemoglobinuria Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Manufacturers (2019-2024)
3.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Sales Sites, Area Served, Product Type
3.6 Paroxysmal Nocturnal Hemoglobinuria Drug Market Competitive Situation and Trends
3.6.1 Paroxysmal Nocturnal Hemoglobinuria Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Paroxysmal Nocturnal Hemoglobinuria Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG INDUSTRY CHAIN ANALYSIS
4.1 Paroxysmal Nocturnal Hemoglobinuria Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2019-2024)
6.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Market Share by Type (2019-2024)
6.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Price by Type (2019-2024)
7 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Sales by Application (2019-2024)
7.3 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Growth Rate by Application (2019-2024)
8 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET SEGMENTATION BY REGION
8.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
8.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
8.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Apellis Pharmaceuticals
9.1.1 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.1.2 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.1.3 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.1.4 Apellis Pharmaceuticals Business Overview
9.1.5 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
9.1.6 Apellis Pharmaceuticals Recent Developments
9.2 Alexion Pharmaceuticals Inc
9.2.1 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.2.2 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.2.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.2.4 Alexion Pharmaceuticals Inc Business Overview
9.2.5 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
9.2.6 Alexion Pharmaceuticals Inc Recent Developments
9.3 Akari Therapeutics Plc
9.3.1 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.3.2 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.3.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.3.4 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
9.3.5 Akari Therapeutics Plc Business Overview
9.3.6 Akari Therapeutics Plc Recent Developments
9.4 CinnaGen Co
9.4.1 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.4.2 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.4.3 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.4.4 CinnaGen Co Business Overview
9.4.5 CinnaGen Co Recent Developments
9.5 Ra Pharmaceuticals Inc
9.5.1 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.5.2 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.5.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.5.4 Ra Pharmaceuticals Inc Business Overview
9.5.5 Ra Pharmaceuticals Inc Recent Developments
9.6 Amgen Inc
9.6.1 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.6.2 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.6.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.6.4 Amgen Inc Business Overview
9.6.5 Amgen Inc Recent Developments
9.7 Achillion Pharmaceuticals Inc
9.7.1 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.7.2 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.7.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.7.4 Achillion Pharmaceuticals Inc Business Overview
9.7.5 Achillion Pharmaceuticals Inc Recent Developments
9.8 Alnylam Pharmaceuticals Inc
9.8.1 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.8.2 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.8.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.8.4 Alnylam Pharmaceuticals Inc Business Overview
9.8.5 Alnylam Pharmaceuticals Inc Recent Developments
9.9 F. Hoffmann-La Roche Ltd
9.9.1 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.9.2 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.9.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.9.4 F. Hoffmann-La Roche Ltd Business Overview
9.9.5 F. Hoffmann-La Roche Ltd Recent Developments
9.10 Novartis AG
9.10.1 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.10.2 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.10.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.10.4 Novartis AG Business Overview
9.10.5 Novartis AG Recent Developments
9.11 Regeneron Pharmaceuticals Inc
9.11.1 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.11.2 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.11.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.11.4 Regeneron Pharmaceuticals Inc Business Overview
9.11.5 Regeneron Pharmaceuticals Inc Recent Developments
9.12 BIOCAD
9.12.1 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.12.2 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.12.3 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.12.4 BIOCAD Business Overview
9.12.5 BIOCAD Recent Developments
9.13 Samsung Bioepis
9.13.1 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.13.2 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.13.3 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.13.4 Samsung Bioepis Business Overview
9.13.5 Samsung Bioepis Recent Developments
9.14 Amyndas Pharmaceuticals
9.14.1 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.14.2 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.14.3 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.14.4 Amyndas Pharmaceuticals Business Overview
9.14.5 Amyndas Pharmaceuticals Recent Developments
9.15 Teva Pharmaceutical Industries Ltd.
9.15.1 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.15.2 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.15.3 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.15.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9.16 LGM Pharma.
9.16.1 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.16.2 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.16.3 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.16.4 LGM Pharma. Business Overview
9.16.5 LGM Pharma. Recent Developments
9.17 Lannett
9.17.1 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.17.2 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.17.3 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.17.4 Lannett Business Overview
9.17.5 Lannett Recent Developments
9.18 NorthStar Rx LLC
9.18.1 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.18.2 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.18.3 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.18.4 NorthStar Rx LLC Business Overview
9.18.5 NorthStar Rx LLC Recent Developments
9.19 Abbott
9.19.1 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.19.2 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.19.3 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.19.4 Abbott Business Overview
9.19.5 Abbott Recent Developments
9.20 Par Pharmaceutical
9.20.1 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
9.20.2 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
9.20.3 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product Market Performance
9.20.4 Par Pharmaceutical Business Overview
9.20.5 Par Pharmaceutical Recent Developments
10 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MARKET FORECAST BY REGION
10.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast
10.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country
10.2.3 Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Region
10.2.4 South America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Paroxysmal Nocturnal Hemoglobinuria Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Paroxysmal Nocturnal Hemoglobinuria Drug by Type (2025-2030)
11.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Paroxysmal Nocturnal Hemoglobinuria Drug by Type (2025-2030)
11.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Forecast by Application (2025-2030)
11.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Comparison by Region (M USD)
Table 5. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Drug as of 2022)
Table 10. Global Market Paroxysmal Nocturnal Hemoglobinuria Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Sales Sites and Area Served
Table 12. Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Product Type
Table 13. Global Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Paroxysmal Nocturnal Hemoglobinuria Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Paroxysmal Nocturnal Hemoglobinuria Drug Market Challenges
Table 22. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (Kilotons)
Table 23. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Type (M USD)
Table 24. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2019-2024)
Table 26. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Share by Type (2019-2024)
Table 28. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) by Application
Table 30. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Application
Table 31. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2019-2024)
Table 33. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Application (2019-2024)
Table 35. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region (2019-2024)
Table 38. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 44. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 45. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Apellis Pharmaceuticals Business Overview
Table 47. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
Table 48. Apellis Pharmaceuticals Recent Developments
Table 49. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 50. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 51. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Alexion Pharmaceuticals Inc Business Overview
Table 53. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
Table 54. Alexion Pharmaceuticals Inc Recent Developments
Table 55. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 56. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 57. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
Table 59. Akari Therapeutics Plc Business Overview
Table 60. Akari Therapeutics Plc Recent Developments
Table 61. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 62. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 63. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. CinnaGen Co Business Overview
Table 65. CinnaGen Co Recent Developments
Table 66. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 67. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 68. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Ra Pharmaceuticals Inc Business Overview
Table 70. Ra Pharmaceuticals Inc Recent Developments
Table 71. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 72. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 73. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Amgen Inc Business Overview
Table 75. Amgen Inc Recent Developments
Table 76. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 77. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 78. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Achillion Pharmaceuticals Inc Business Overview
Table 80. Achillion Pharmaceuticals Inc Recent Developments
Table 81. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 82. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 83. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Alnylam Pharmaceuticals Inc Business Overview
Table 85. Alnylam Pharmaceuticals Inc Recent Developments
Table 86. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 87. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 88. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. F. Hoffmann-La Roche Ltd Business Overview
Table 90. F. Hoffmann-La Roche Ltd Recent Developments
Table 91. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 92. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 93. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Novartis AG Business Overview
Table 95. Novartis AG Recent Developments
Table 96. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 97. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 98. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Regeneron Pharmaceuticals Inc Business Overview
Table 100. Regeneron Pharmaceuticals Inc Recent Developments
Table 101. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 102. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 103. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BIOCAD Business Overview
Table 105. BIOCAD Recent Developments
Table 106. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 107. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 108. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Samsung Bioepis Business Overview
Table 110. Samsung Bioepis Recent Developments
Table 111. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 112. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 113. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Amyndas Pharmaceuticals Business Overview
Table 115. Amyndas Pharmaceuticals Recent Developments
Table 116. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 117. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 118. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Teva Pharmaceutical Industries Ltd. Business Overview
Table 120. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 121. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 122. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 123. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. LGM Pharma. Business Overview
Table 125. LGM Pharma. Recent Developments
Table 126. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 127. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 128. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Lannett Business Overview
Table 130. Lannett Recent Developments
Table 131. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 132. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 133. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. NorthStar Rx LLC Business Overview
Table 135. NorthStar Rx LLC Recent Developments
Table 136. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 137. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 138. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Abbott Business Overview
Table 140. Abbott Recent Developments
Table 141. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 142. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 143. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Par Pharmaceutical Business Overview
Table 145. Par Pharmaceutical Recent Developments
Table 146. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Comparison by Region (M USD)
Table 5. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paroxysmal Nocturnal Hemoglobinuria Drug as of 2022)
Table 10. Global Market Paroxysmal Nocturnal Hemoglobinuria Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Sales Sites and Area Served
Table 12. Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Product Type
Table 13. Global Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Paroxysmal Nocturnal Hemoglobinuria Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Paroxysmal Nocturnal Hemoglobinuria Drug Market Challenges
Table 22. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Type (Kilotons)
Table 23. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Type (M USD)
Table 24. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Type (2019-2024)
Table 26. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Share by Type (2019-2024)
Table 28. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) by Application
Table 30. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Application
Table 31. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2019-2024)
Table 33. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Application (2019-2024)
Table 35. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region (2019-2024)
Table 38. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 44. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 45. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Apellis Pharmaceuticals Business Overview
Table 47. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
Table 48. Apellis Pharmaceuticals Recent Developments
Table 49. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 50. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 51. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Alexion Pharmaceuticals Inc Business Overview
Table 53. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
Table 54. Alexion Pharmaceuticals Inc Recent Developments
Table 55. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 56. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 57. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug SWOT Analysis
Table 59. Akari Therapeutics Plc Business Overview
Table 60. Akari Therapeutics Plc Recent Developments
Table 61. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 62. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 63. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. CinnaGen Co Business Overview
Table 65. CinnaGen Co Recent Developments
Table 66. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 67. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 68. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Ra Pharmaceuticals Inc Business Overview
Table 70. Ra Pharmaceuticals Inc Recent Developments
Table 71. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 72. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 73. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Amgen Inc Business Overview
Table 75. Amgen Inc Recent Developments
Table 76. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 77. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 78. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Achillion Pharmaceuticals Inc Business Overview
Table 80. Achillion Pharmaceuticals Inc Recent Developments
Table 81. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 82. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 83. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Alnylam Pharmaceuticals Inc Business Overview
Table 85. Alnylam Pharmaceuticals Inc Recent Developments
Table 86. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 87. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 88. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. F. Hoffmann-La Roche Ltd Business Overview
Table 90. F. Hoffmann-La Roche Ltd Recent Developments
Table 91. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 92. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 93. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Novartis AG Business Overview
Table 95. Novartis AG Recent Developments
Table 96. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 97. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 98. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Regeneron Pharmaceuticals Inc Business Overview
Table 100. Regeneron Pharmaceuticals Inc Recent Developments
Table 101. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 102. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 103. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BIOCAD Business Overview
Table 105. BIOCAD Recent Developments
Table 106. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 107. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 108. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Samsung Bioepis Business Overview
Table 110. Samsung Bioepis Recent Developments
Table 111. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 112. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 113. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Amyndas Pharmaceuticals Business Overview
Table 115. Amyndas Pharmaceuticals Recent Developments
Table 116. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 117. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 118. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Teva Pharmaceutical Industries Ltd. Business Overview
Table 120. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 121. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 122. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 123. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. LGM Pharma. Business Overview
Table 125. LGM Pharma. Recent Developments
Table 126. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 127. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 128. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Lannett Business Overview
Table 130. Lannett Recent Developments
Table 131. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 132. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 133. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. NorthStar Rx LLC Business Overview
Table 135. NorthStar Rx LLC Recent Developments
Table 136. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 137. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 138. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Abbott Business Overview
Table 140. Abbott Recent Developments
Table 141. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Basic Information
Table 142. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product Overview
Table 143. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Par Pharmaceutical Business Overview
Table 145. Par Pharmaceutical Recent Developments
Table 146. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Paroxysmal Nocturnal Hemoglobinuria Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Paroxysmal Nocturnal Hemoglobinuria Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD), 2019-2030
Figure 5. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) (2019-2030)
Figure 6. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Country (M USD)
Figure 11. Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Manufacturers in 2023
Figure 12. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Manufacturers in 2023
Figure 13. Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Paroxysmal Nocturnal Hemoglobinuria Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Paroxysmal Nocturnal Hemoglobinuria Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Type
Figure 18. Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria Drug by Type (2019-2024)
Figure 19. Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria Drug by Type in 2023
Figure 20. Market Size Share of Paroxysmal Nocturnal Hemoglobinuria Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Paroxysmal Nocturnal Hemoglobinuria Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Application
Figure 24. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application in 2023
Figure 26. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Application (2019-2024)
Figure 27. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Application in 2023
Figure 28. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Country in 2023
Figure 32. U.S. Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Country in 2023
Figure 37. Germany Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region in 2023
Figure 44. China Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Country in 2023
Figure 51. Brazil Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Paroxysmal Nocturnal Hemoglobinuria Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD), 2019-2030
Figure 5. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size (M USD) (2019-2030)
Figure 6. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Paroxysmal Nocturnal Hemoglobinuria Drug Market Size by Country (M USD)
Figure 11. Paroxysmal Nocturnal Hemoglobinuria Drug Sales Share by Manufacturers in 2023
Figure 12. Global Paroxysmal Nocturnal Hemoglobinuria Drug Revenue Share by Manufacturers in 2023
Figure 13. Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Paroxysmal Nocturnal Hemoglobinuria Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Paroxysmal Nocturnal Hemoglobinuria Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Type
Figure 18. Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria Drug by Type (2019-2024)
Figure 19. Sales Market Share of Paroxysmal Nocturnal Hemoglobinuria Drug by Type in 2023
Figure 20. Market Size Share of Paroxysmal Nocturnal Hemoglobinuria Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Paroxysmal Nocturnal Hemoglobinuria Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Application
Figure 24. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Application in 2023
Figure 26. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Application (2019-2024)
Figure 27. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share by Application in 2023
Figure 28. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Country in 2023
Figure 32. U.S. Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Paroxysmal Nocturnal Hemoglobinuria Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Country in 2023
Figure 37. Germany Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region in 2023
Figure 44. China Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Country in 2023
Figure 51. Brazil Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Paroxysmal Nocturnal Hemoglobinuria Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Paroxysmal Nocturnal Hemoglobinuria Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Paroxysmal Nocturnal Hemoglobinuria Drug Market Share Forecast by Application (2025-2030)
